Results from the Long-Term Open Label Extension Phase Analyses of BHV4157-201: A Phase IIb/III, Randomized, Double-blind, Placebo-controlled Trial of the Safety and Efficacy of Troriluzole in Adult Subjects with Spinocerebellar Ataxia (P1.8-001)
Beiner M, Wirtz V, Coric V, Berman R, L’Italien G. Results from the Long-Term Open Label Extension Phase Analyses of BHV4157-201: A Phase IIb/III, Randomized, Double-blind, Placebo-controlled Trial of the Safety and Efficacy of Troriluzole in Adult Subjects with Spinocerebellar Ataxia (P1.8-001). Neurology 2019, 92 DOI: 10.1212/wnl.92.15_supplement.p1.8-001.Peer-Reviewed Original Research